Breaking News

Bioclinica Expands eHealth Solutions Team

March 28, 2016

Herne and Audibert to lead eHealth Solutions team

Bioclinica, Inc., a specialty clinical trials technology and services provider, has added two global executive positions to the eHealth Solutions team. Steven Herne has been appointed chief commercial officer and Francois Audibert was named vice president for global consulting.
Mr. Herne will head eHealth Solutions global commercial endeavors across all three of Bioclinica’s eHealth divisions: eClinical, Safety & Regulatory, and Financial Lifecycle Solutions. Mr. Herne most recently served as chief commercial officer at ERT where he was responsible for creating and executing the long-term strategic growth plan across all business lines. Previously he was senior vice president, global business development at ICON tasked with directing the development and prioritization of business generated through key new strategic ventures.
Mr. Audibert will lead the company’s global consulting practice specializing in data sciences, safety system and process and will head the company’s life sciences big data strategy. Mr. Audibert is a 30-year industry veteran in life sciences technology. He brings expertise in technology, strategy and business having worked on some of the world’s largest drug safety implementations within a global regulatory and distribution environment. Most recently he was vice president of pharmacovigilance at HighPoint Solutions, and was a safety solutions director at Oracle.
“Expanding our eHealth leadership team with knowledgeable industry veterans like Steven and Francois will help steer Bioclinica’s transformative industry solutions in partnership with CROs, sponsors and the broader research community,” said Bioclinica eHealth Solutions president Mukhtar Ahmed.
  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials